We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

7 hedge funds and large institutions have $18.7M invested in Aptose Biosciences, Inc. in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$9.47M
2
CAM
Cormorant Asset Management
Massachusetts
+$7.24M
3
BBA
Baker Bros. Advisors
New York
+$3.2M
4
BI
BVF Inc
California
+$1.11M
5
TRCT
Tower Research Capital (TRC)
New York
+$36.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$8.38M +$9.47M +3,148 New
CAM
2
Cormorant Asset Management
Massachusetts
$6.4M +$7.24M +2,407 New
BBA
3
Baker Bros. Advisors
New York
$2.83M +$3.2M +1,065 New
BI
4
BVF Inc
California
$986K +$1.11M +370 New
TRCT
5
Tower Research Capital (TRC)
New York
$31K +$36.1K +12 New
UBS Group
6
UBS Group
Switzerland
$23K +$24.1K +8 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$23K +$27.1K +9 New

APTO Hedge Fund Activity: Q4 2014 in Review

7 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2014, worth a combined $18.7M.

Buyers outnumbered sellers: 7 funds opened new APTO positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $9.47M.

  • 7 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $18.7M of Aptose Biosciences, Inc. stock for Q4 2014.
  • 7 funds opened new Aptose Biosciences, Inc. positions in Q4 2014 and 0 closed out, a net change of +7 holders.
  • The largest Aptose Biosciences, Inc. buyer in Q4 2014 was Franklin Resources, an estimated $9.47M added.

Based on aggregated 13F filings for Q4 2014.